You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
|
|---|---|
| Published in |
BMC Infectious Diseases, July 2008
|
| DOI | 10.1186/1471-2334-8-103 |
| Pubmed ID | |
| Authors |
Atanacio Valencia-Mendoza, Stefano M Bertozzi, Juan-Pablo Gutierrez, Robbin Itzler |
| Abstract |
In developing countries rotavirus is the leading cause of severe diarrhoea and diarrhoeal deaths in children under 5. Vaccination could greatly alleviate that burden, but in Mexico as in most low- and middle-income countries the decision to add rotavirus vaccine to the national immunisation program will depend heavily on its cost-effectiveness and affordability. The objective of this study was to assess the cost-effectiveness of including the pentavalent rotavirus vaccine in Mexico's national immunisation program. |
Mendeley readers
The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| Kenya | 1 | <1% |
| South Africa | 1 | <1% |
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 122 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 23% |
| Student > Master | 27 | 21% |
| Student > Ph. D. Student | 15 | 12% |
| Student > Bachelor | 13 | 10% |
| Student > Postgraduate | 8 | 6% |
| Other | 18 | 14% |
| Unknown | 18 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 30% |
| Social Sciences | 13 | 10% |
| Nursing and Health Professions | 10 | 8% |
| Agricultural and Biological Sciences | 9 | 7% |
| Economics, Econometrics and Finance | 9 | 7% |
| Other | 22 | 17% |
| Unknown | 26 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2022.
All research outputs
#7,605,706
of 23,189,371 outputs
Outputs from BMC Infectious Diseases
#2,608
of 7,777 outputs
Outputs of similar age
#29,133
of 82,680 outputs
Outputs of similar age from BMC Infectious Diseases
#7
of 16 outputs
Altmetric has tracked 23,189,371 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,777 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 82,680 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.